Top Markets
Coin of the day
REYON Pharmaceutical Co., Ltd. REYON Pharmaceutical Co., Ltd.

REYON Pharmaceutical Co., Ltd.

102460
Rang in Aktien #20565
Operating both domestically in South Korea and across international markets,... Operating both domestically in South Korea and across international markets, REYON Pharmaceutical Co., Ltd. specializes in the production and distribution of pharmaceutical products and active pharmaceutical ingredients (APIs). The company's diverse range of offerings addresses various therapeutic areas, including adrenal corticosteroids; angiotensin II receptor antagonists; anticholinergics; antiemetics; antihypertensives; anti-inflammatory enzymes; lipid-lowering, antirheumatic, and oral hypoglycemic agents; anti-peptic ulcer treatments; antispasmodics; benign prostatic hypertrophy therapies; cough and cold remedies; cardiac stimulants; genitourinary smooth muscle relaxants; hemostatics; immunosuppressants; rheumatoid arthritis medications; local anesthetics; migraine drugs; a variety of cardiovascular system drugs; medications for neuromuscular disorders; nootropics and neurotonics; non-steroidal anti-inflammatory drugs (NSAIDs); respiratory stimulants; skeletal muscle relaxants; and vasodilators. Established in 1955, REYON Pharmaceutical Co., Ltd. maintains its corporate headquarters in Seoul, South Korea.
Aktienkurs
$6.92
Marktkapitalisierung
$126.95M
Veränderung (1 Tag)
0.10%
Veränderung (1 Jahr)
-11.37%
Land
KR
Handel REYON Pharmaceutical Co., Ltd. (102460)

Kategorie

Aktien-Split-Historie für REYON Pharmaceutical Co., Ltd. (102460)
Die Aktie REYON Pharmaceutical Co., Ltd. (Symbol: 102460) durchlief insgesamt 0 Aktiensplits.
Der letzte Aktiensplit fand am Aug 24, 2026 statt.
Eine 102460-Aktie, die vor dem Aug 24, 2026 gekauft wurde, entspricht heute 0 102460-Aktien.
Liste der Aktiensplits
Jahr Aktien-Split Multiplikator Kumulierter Multiplikator
Nicht genügend Daten für die angegebenen Daten.
Aktiensplits ähnlicher Unternehmen oder Wettbewerber